{
  "docId": "019de074-4761-73aa-b4e2-27087123bde2",
  "docSlug": "6f8a02d6c80778306574b231840d422a",
  "documentTitle": "argenx SE | Investor Presentation Deck | 23 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 15,
  "pageCount": 23,
  "prevPage": 14,
  "nextPage": 16,
  "slideType": "propose_solution",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide highlights the mechanism of action (sweeping antibody) and the clinical pipeline strategy for ARGX-117.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-4761-73aa-b4e2-27087123bde2/15",
  "deckHref": "/decks/019de074-4761-73aa-b4e2-27087123bde2",
  "deckJsonHref": "/decks/019de074-4761-73aa-b4e2-27087123bde2.json",
  "deckAnchorHref": "/decks/019de074-4761-73aa-b4e2-27087123bde2#slide-15",
  "components": [
    {
      "bbox": {
        "h": 0.28,
        "w": 0.15,
        "x": 0.83,
        "y": 0.01
      },
      "kind": "callout",
      "text": "clinical Broaden immunology pipeline",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3033efeb-dde9-45d5-9538-023d19063d3a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.25,
        "x": 0.05,
        "y": 0.4
      },
      "kind": "image",
      "text": "Diagram of a sweeping antibody showing pH/Ca2+ switch, optimal recycling, and no effector function.",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "addf0773-ee89-49d0-99e5-730892c35538",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.6,
        "x": 0.35,
        "y": 0.35
      },
      "kind": "list",
      "text": "Indication selection starts with autoimmune diseases driven by classical and/or lectin pathway; Phase 2 proof-of-concept trial underway in multifocal motor neuropathy (MMN) with interim data expected in mid-2023; Phase 2 trials to start in delayed graft function and dermatomyositis",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c6a37b87-78ff-4af6-bd12-8782ca093276",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.14,
        "w": 0.45,
        "x": 0.03,
        "y": 0.04
      },
      "kind": "title",
      "text": "ARGX-117: Targets C2 at Junction of Classical and Lectin Pathways",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "14e2c593-8dc8-4673-928f-213742d6d2ca",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "26a0a893-3684-475b-937f-3962999c75ce",
      "evidence": "The use of a bullet list to present indication selection criteria suggests a clear and concise presentation of information.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 23,
      "from": 11,
      "beatId": "8377a19c-fd86-459c-a277-82f98dddc5e0",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "New Bliss",
      "beatSlug": "sparkline-new-bliss",
      "evidence": "Proposed solutions, pipeline, and growth opportunities",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 20,
      "from": 15,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "3a9ec336-a024-4e02-b770-24d1e84c97c4",
      "evidence": "The presentation showcases ARGX-117 and ARGX-119 as significant opportunities",
      "position": 2,
      "objective": "Quick wins and big bets",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.7,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}